Aleksandra Mazurek

Aleksandra Mazurek

Auto-generated profile, based on publicly available information

Aleksandra Mazurek

Student Scientific Association at Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, ul. Radziwiłłowska 11, Lublin 20-080, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AMAleksandra Mazurek
Aleksandra Mazurek
MPMateusz Pawlicki
Mateusz Pawlicki
KSKarol Stachyrak
Karol Stachyrak
DMDawid Mika
Dawid Mika
BMBartosz Mazur
Bartosz Mazur
WWWiktoria Wilanowska
Wiktoria Wilanowska
Introduction and purpose : Type 2 diabetes is currently a serious problem worldwide. Each year, the number of individuals with carbohydrate metabolism disorders is increasing. This is due to an unhealthy lifestyle, lack of physical activity, and a diet rich in highly processed foods. Currently, the treatment of type 2 diabetes is based on the use of oral antidiabetic medications, with the first choice often being a derivative of biguanides, such as metformin. Berberine has been used in China for many years as a hypoglycemic agent, and its efficacy is compared to metformin preparations. This paper focuses on the benefits of using berberine in patients with prediabetes or type 2 diabetes and compares the effects of berberine preparations to classical medications used in diabetes treatment. Material and methods : The literaue was reviewed in PubMed and Google Scholar scientific database in 2013-2023 using the following keywords : berberine, diabetes mellitus type 2, hyperlipidemia, hyperglicemia Conclusions : The studies included in this manuscript have shown that berberine is a promising agent for adjunctive treatment in type 2 diabetes. It exhibits a range of positive effects such as lowering blood glucose levels, improving lipid profile, with no serious adverse effects reported. However, further research is needed to confirm these findings and develop an effective treatment plan.

15 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
DMDawid Mika
Dawid Mika
KTKamila Turek
Kamila Turek
AGAnna Greguła
Anna Greguła
AKAleksandra Kłos
Aleksandra Kłos
BMBartosz Mazur
Bartosz Mazur
MLMaciej Lambach
Maciej Lambach
Introduction and purpose Acute appendicitis, a common surgical abdominal ailment, mostly affects individuals in their second or third decade of life, with an annual incidence of about 100 cases per 100,000 persons. This literature review aims to synthesize evidence from diverse sources, summarizing optimal practices for clinical implementation. Surgical intervention, achieving almost 100% cure rates, remains the gold standard, emphasizing challenges in patient qualification for non-surgical approachesNon-operative treatment, considered safe for uncomplicated cases, involves antibiotic therapy, with concerns about antibiotic resistance. Summarizing the current understanding of antibiotic therapy of appendicitis seeks to enhance its effective use, decrease adverse incidents in patients, and contribute to the overall safety of both patients and healthcare providers. Material and methods The following review of studies was based on articles obtained from the PubMed and Google Scholar databases. Key search terms included acute appendicitis, acute appendicitis conservative treatment, appendectomy, surgical abdominal diaseases, antibiothic therapy. Conclusions
The literature review highlights the existing challenges in the management of acute appendicitis, acknowledging the efficacy of both methods. While surgical intervention with high cure rates, the increasing popularity of non-operative therapy encourages optimism for comprehensive research in the future. The need for large, randomized studies comparing long-term clinical effectiveness is emphasized, aiming to inform decision-making and optimize patient outcomes.

12 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KSKarol Stachyrak
Karol Stachyrak
AGAnna Gregułą
Anna Gregułą
BMBartosz Mazur
Bartosz Mazur
DMDawid Mika
Dawid Mika
AKAleksandra Kłos
Aleksandra Kłos
WWWiktoria Wilanowska
Wiktoria Wilanowska
Introduction             In contemporary medicine, increasing attention is being devoted to alternative forms of therapy. Immersing oneself in cold water, cryotherapy, or cold showers are practices that have long sparked interest due to their potential health benefits. Aim of the study The aim of this comprehensive review is to analyze the impact of cold exposure on the human body, with particular emphasis on its effects on the nervous system. Through the synthesis of available research, the paper seeks to identify health benefits and areas requiring further investigation in the context of various cold application practices. Materials and methods             An analysis of scientific articles available in the Pubmed and Google Scholar databases was conducted. Publications from recent years that most relevantly addressed the discussed topic were utilized for this study. The search process involved the use of the following keywords: “cold,” “cold showering,” “cold water,” “cryotherapy.” Results The results of the literature review unequivocally indicate a positive, multifaceted impact of cold on the human body, particularly with an emphasis on the nervous system. Significant therapeutic effects observed in various fields suggest that the application of cold may be a promising alternative in promoting health and treating numerous medical conditions. Summary             The focused literature review on the impact of cold on the human body, especially the nervous system, presents various therapies such as cryotherapy or cold water immersion, emphasizing their beneficial effects on the nervous, cardiovascular, endocrine, lymphatic, musculoskeletal, and joint systems. However, despite the observed benefits, further research is needed to gain a more detailed understanding of the mechanisms of action and to ensure the safety of these practices.

16 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AGAnna Greguła
Anna Greguła
BMBartosz Mazur
Bartosz Mazur
KSKarol Stachyrak
Karol Stachyrak
DMDawid Mika
Dawid Mika
AKAleksandra Kłos
Aleksandra Kłos
WWWiktoria Wilanowska
Wiktoria Wilanowska
Introduction Curcumin, the active ingredient in turmeric, is gaining increasing attention due to its potential health benefits, especially in the context of its immunomodulatory and anticancer properties. Aim of the study The aim of this review was to discuss recent findings regarding the impact of curcumin on the immune system and its potential applications in anticancer therapy. Materials and methods The paper was created based on the Pubmed and Scholar database. The literature was reviewed using the keywords: „curcumin”, „immunomodulatory effects”, „cytokines”, „anticancer”, „apoptosis”, „cell proliferation”, „radiosensitizing”. Results Studies have confirmed that curcumin, especially in the form of nanocurcumin, exhibits significant immunomodulatory effects. It reduces the number of Th17 cells, increases Treg cells, and regulates the expression of pro-inflammatory cytokines, which is crucial in controlling autoimmune reactions. Furthermore, it demonstrates anticancer activity by inhibiting the growth of cancer cells, stimulating apoptosis, and enhancing the effectiveness of anticancer therapy. Conclusions Despite promising results, further research on the safety of curcumin therapy, particularly in the long term, is essential. Limitations associated with bioavailability and pharmacokinetics suggest the need for the development of formulations with increased bioavailability to maximize the potential benefits of curcumin in the treatment of various disorders.

16 May 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MPMateusz Maciej Pawlicki
Mateusz Maciej Pawlicki
AKAleksandra Kłos
Aleksandra Kłos
KSKarol Stachyrak
Karol Stachyrak
DMDawid Mika
Dawid Mika
BMBartosz Mazur
Bartosz Mazur
WWWiktoria Wilanowska
Wiktoria Wilanowska
Introduction: Mental disorders are common and still growing problem around the globe. Significantly decreasing quality of life, they are often source of true suffering for patients and their families leading to further health issues or even dramatic outcomes resulting in death. As public awareness rises, more and more people understand risks and tend to look for help as fast as possible. Currently available treatment methods are not always efficient enough to deal with more complex cases. Therefore it is important to look for new therapy options incrementing chances of fast and successful treatment. Results: Studies showed that psilocybin is not only able to lower depression and anxiety scores in patients with major depressive disorders or with serious life-threatening conditions but also proved this effect to be long-lasting. At the same time, no or little adverse side effects were noticed. Conclusions: Psilocybin is potentially a good method for depression treatment in some groups of patients. It should be considered if other, better known therapies show little or no effects.

9 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
WWWiktoria Wilanowska
Wiktoria Wilanowska
AGAnna Greguła
Anna Greguła
KSKarol Stachyrak
Karol Stachyrak
DMDawid Mika
Dawid Mika
AKAleksandra Kłos
Aleksandra Kłos
BMBartosz Mazur
Bartosz Mazur
IntroductionViloxazine is an antidepressant medication classified as an SNRI (serotonin and norepinephrine reuptake inhibitor). In April 2021, it received FDA approval in the United States for the treatment of ADHD in children aged 6 to 17. Subsequently, in May 2022, it was also approved for the treatment of adults with ADHD [1]. Viloxazine, available in extended-release capsules, represents novel non-stimulant medication option for patients with ADHD.Aim of the studyOur aim was to review the viloxazine in the fields of ADHD treatment, summarize current knowledge and analyze the first treatment results. Methods and materialsA review of the literature available in the PubMed database was performed, using the key words: „Viloxazine" ; „ADHD treatment" ; „ADHD”, „attention deficit hyperactivity disorder”, „attention deficit hyperactivity disorder treatment”; „ADHD non-stimulant treatment”; „ADHD non-stimulant”; „ADHD non-stimulant drugs”, „SPN-812” ConclusionViloxazine presents a promising non-stimulant alternative for ADHD treatment with more favorable pharmacokinetics, new way of possible administration and fewer adverse effects, particularly within the cardiovascular system, than other available ADHD medication options. While these findings are encouraging, continual research is imperative to establish the long-term safety profile.